Preferential nuclear localization of the human papillomavirus type 16 E6 oncoprotein in cervical carcinoma cells

Journal of General Virology

Volumn 84, Issue 8, 2003, Pages 2099-2104

  Masson, Murielle ^a   Hindelang, Colette ^b   Sibler, Annie Paule ^a   Schwalbach, Georges ^a   Travé, Gilles ^a   Weiss, Etienne ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CHIMERIC PROTEIN; MONOCLONAL ANTIBODY; ONCOPROTEIN; RIBONUCLEOPROTEIN; VIRUS PROTEIN;

AMINO ACID SEQUENCE; CANCER CELL; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE OVEREXPRESSION; GENETIC CODE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RIBOSOME; SEROTYPE; SHORT SURVEY; UTERINE CERVIX CARCINOMA; WART VIRUS;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; CARCINOMA; CELL LINE; CELL NUCLEUS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HELA CELLS; HUMANS; MICROSCOPY, ELECTRON; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; REPRESSOR PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS; PAPOVAVIRIDAE;

EID: 0043169538     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.18961-0     Document Type: Short Survey

References (29)

1. Bernhard, W. (1969). A new staining procedure for electron microscopical cytology. J Ultrastruct Res 27, 250-265.
2. Choulier, L., Orfanoudakis, G., Robinson, P., Laune, D., Ben Khalifa, M., Granier, C., Weiss, E. & Altschuh, D. (2002). Comparative properties of two peptide-antibody interactions as deduced from epitope delineation. J Immunol Methods 259, 77-86.
3. Cmarko, D., Verschure, P. J., Martin, T. E., Dahmus, M. E., Krause, S., Fu, X. D., van Driel, R. & Fakan, S. (1999). Ultrastructural analysis of transcription and splicing in the cell nucleus after bromo-UTP microinjection. Mol Biol Cell 10, 211-223.
4. Daniels, P. R., Sanders, C. M. & Maitland, N. J. (1998). Characterization of the interactions of human papillomavirus type 16 E6 with p53 and E6-associated protein in insect and human cells. J Gen Virol 79, 489-499.
5. Giovane, C., Travé, G., Briones, A., Lutz, Y., Wasylyk, B. & Weiss, E. (1999). Targetting of the N-terminal domain of the human papillomavirus type 16 E6 oncoprotein with monomeric ScFvs blocks the E6-mediated degradation of cellular p53. J Mol Recognit 12, 141-152.
6. Gross-Mesilaty, S., Reinstein, E., Bercovich, B., Tobias, K. E., Schwartz, A. L., Kahana, C. & Ciechanover, A. (1998). Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway. Proc Natl Acad Sci U S A 95, 8058-8063.
7. Guccione, E., Massimi, P., Bernat, A. & Banks, L. (2002). Comparative analysis of the intracellular location of the high- and low-risk human papillomavirus oncoproteins. Virology 293, 20-25.
8. Hendzel, M. J., Kruhlak, M. J. & Bazett-Jones, D. P. (1998). Organization of highly acetylated chromatin around sites of heterogeneous nuclear RNA accumulation. Mol Biol Cell 9, 2491-2507.
9. Kanda, T., Watanabe, S., Zanma, S., Sato, H., Furuno, A. & Yoshiike, K. (1991). Human papillomavirus type 16 E6 proteins with glycine substitution for cysteine in the metal-binding motif. Virology 185, 536-543.
10. Klingelhutz, A. J., Foster, S. A. & McDougall, J. K. (1996). Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380, 79-82.
11. Kumar, A., Zhao, Y., Meng, G. & 9 other authors (2002). Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3. Mol Cell Biol 22, 5801-5812.
12. Lechner, M. S., Mack, D. H., Finicle, A. B., Crook, T., Vousden, K. H. & Laimins, L. A. (1992). Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription. EMBO J 11, 3045-3052.
13. Le Roux, L. G. & Moroianu, J. (2003). Nuclear entry of high-risk human papillomavirus type 16 E6 oncoprotein occurs via several pathways. J Virol 77, 2330-2337.
14. Liang, X. H., Volkmann, M., Klein, R., Herman, B. & Lockett, S. J. (1993). Co-localization of the tumor-suppressor protein p53 and human papillomavirus E6 protein in human cervical carcinoma cell lines. Oncogene 8, 2645-2652.
15. Mantovani, F. & Banks, L. (2001). The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20, 7874-7887.
16. Patel, D., Huang, S. M., Baglia, L. A. & McCance, D. J. (1999). The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO J 18, 5061-5072.
17. Pim, D., Thomas, M., Javier, R., Gardiol, D. & Banks, L. (2000). HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase. Oncogene 19, 719-725.
18. Ristriani, T., Masson, M., Nominé, Y., Laurent C., Lefèvre, J. F., Weiss, E. & Travé, G. (2000). HPV oncoprotein E6 is a structure-dependent DNA-binding protein that recognizes four-way junctions. J Mol Biol 296, 1189-1203.
19. Ristriani, T., Nominé, Y., Masson, M., Weiss, E. & Travé, G. (2001). Specific recognition of four-way DNA junctions by the C-terminal zinc-binding domain of HPV oncoprotein E6. J Mol Biol 305, 729-739.
20. Ronco, L. V., Karpova, A. Y., Vidal, M. & Howley, P. M. (1998). Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev 12, 2061-2072.
21. Scheffner, M., Takahashi, T., Huibregtse, J. M., Minna, J. D. & Howley, P. M. (1992). Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins. J Virol 66, 5100-5105.
22. Schwalbach, G., Sibler, A. P., Choulier, L., Deryckere, F. & Weiss, E. (2000). Production of fluorescent single-chain antibody fragments in Escherichia coli. Protein Expr Purif 18, 121-132.
23. Sherman, L. & Schlegel, R. (1996). Serum- and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16. J Virol 70, 3269-3279.
24. Sorg, G. & Stamminger, T. (1999). Mapping of nuclear localization signals by simultaneous fusion to green fluorescent protein and to β-galactosidase. Biotechniques 26, 858-862.
25. Spector, D. L., Fu, X. D. & Maniatis, T. (1991). Associations between distinct pre-mRNA splicing components and the cell nucleus. EMBO J 10, 3467-3481.
26. Stoeckel, M. E., Schimchowitsch, S., Garaud, J. C., Schmitt, G., Vaudry, H., Klein, M. J. & Porte, A. (1985). Immunocytochemical evidence for intragranular processing of pro-opiomelanocortin in the melanotropic cells of the rabbit. Cell Tissue Res 242, 365-370.
27. Weiss, D. J., Ligitt, D. & Clark, J. G. (1997). In situ histochemical detection of β-galactosidase activity in lung: assessment of X-Gal reagent in distinguishing lacZ gene expression and endogeous β-galactosidase activity. Hum Gene Ther 8, 1545-1554.
28. Yoneda, Y. (2000). Nucleocytoplasmic protein traffic and its significance to cell function. Genes Cells 5, 777-787.
29. zur Hausen, H. (1999). Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes. Semin Cancer Biol 9, 405-411.